This topic contains a solution. Click here to go to the answer

Author Question: Which pre-competition goal is not directly associated with carbohydrate intake? A) Avoiding hunger ... (Read 22 times)

cookcarl

  • Hero Member
  • *****
  • Posts: 539
Which pre-competition goal is not directly associated with carbohydrate intake?
 A) Avoiding hunger
  B) Delaying fatigue
  C) Minimizing gastrointestinal distress
  D) Preventing hypohydration

Question 2

The recommended amount of daily carbohydrate for athletes engaged in high-intensity, short-duration exercise is ____.
 A) 5 g/kg of body weight
  B) 5-7 g/kg of body weight
  C) 6-8 g/kg of body weight
  D) 8+ g/kg of body weight



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

britb2u

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

D

Answer to Question 2

B




cookcarl

  • Member
  • Posts: 539
Reply 2 on: Aug 21, 2018
YES! Correct, THANKS for helping me on my review


Viet Thy

  • Member
  • Posts: 329
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Adolescents often feel clumsy during puberty because during this time of development, their hands and feet grow faster than their arms and legs do. The body is therefore out of proportion. One out of five adolescents actually experiences growing pains during this period.

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

Did you know?

If you could remove all of your skin, it would weigh up to 5 pounds.

Did you know?

All patients with hyperparathyroidism will develop osteoporosis. The parathyroid glands maintain blood calcium within the normal range. All patients with this disease will continue to lose calcium from their bones every day, and there is no way to prevent the development of osteoporosis as a result.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library